Cargando…
Posterior Reversible Encephalopathy Syndrome (PRES) in a Patient With Primary Myelofibrosis on Ruxolitinib
Posterior reversible encephalopathy syndrome (PRES) is a reversible neurological syndrome characterized by headache, seizures, altered mental status, and visual abnormalities, in association with the characteristic bilateral white matter abnormalities in the posterior cerebral hemispheres. As the na...
Autores principales: | Shanthosh Kumar, Sandhya, Nagesh, Vignesh Krishnan, Sivakolundu, Keerthana P, Ali, Bahadur, Sange, Ibrahim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513730/ https://www.ncbi.nlm.nih.gov/pubmed/34660133 http://dx.doi.org/10.7759/cureus.17944 |
Ejemplares similares
-
Nivolumab-Induced PRES (Posterior Reversible Encephalopathy Syndrome)
por: Yashi, Kanica, et al.
Publicado: (2023) -
A Case of Severe Hyponatremia in a Patient With Primary Adrenal Insufficiency
por: Shanthosh Kumar, Sandhya, et al.
Publicado: (2021) -
Persistent Cortical Blindness Following Posterior Reversible Encephalopathy Syndrome (PRES) as a Complication of COVID-19 Pneumonia
por: Elhassan, Mohamed, et al.
Publicado: (2021) -
Ruxolitinib Reduces Oxidative Stress in Patients With Primary Myelofibrosis: A Multicenter Study
por: Koyuncu, Mahmut B, et al.
Publicado: (2022) -
Chronic Glomerulonephritis and Malignant Hypertension With PRES (Posterior Reversible Encephalopathy Syndrome) Presenting As Status Epilepticus: A Case Report
por: Khurana, Kashish, et al.
Publicado: (2023)